Analysis: How COVID-19 Vaccination Rates Vary Across Different Communities

October 20, 2021Garrett SchmittNo CommentsBiden administration, BioNTech, CMS, community health, Coronavirus, COVID, COVID-19, COVID-19 pandemic, COVID-19 vaccine, EUA, FDA, Janssen, Johnson & Johnson, Medicare, Moderna, Pfizer, Pfizer-BioNTech

The year of 2020 was dominated by the news of how COVID-19 spread around the world, and how life has been changed by the disruption of this pandemic. We have witnessed the journeys of battling the disease, dedication and sacrifices by the front-line heroes, and the emotional roller coaster of wondering when this pandemic would…

Gottlieb: COVID-19’s Lasting Effects on Healthcare Delivery

September 13, 2021Garrett SchmittNo CommentsCoronavirus, COVID-19, FDA, Gottlieb, pandemic, Scott Gottlieb

The COVID-19 pandemic has forever changed how healthcare is and will be delivered in the future, Scott Gottlieb, M.D., former commissioner of the FDA, said during his keynote address today at the 2021 Pharmacy Benefit Management Institute®Annual National Conference in Orlando, Florida. The future of healthcare is going to be very different from what it is now,…

Recent Posts

  • Value-Based Care Emerges as a Strategic Anchor in an Uncertain Regulatory Climate
  • Around the nation: Optum launches new AI tool for value-based care
  • Podcast: Is Value-Based Payment Failing U.S. Healthcare?
  • Medicare Alternative Payment Models That Support Improved Primary Care
  • RECORDED WEBINAR: The Missing Layer in Value-Based Care: Turning Performance into Financial Truth
 
  • Main Lobby
  • Exhibit Hall
  • Events
  • Exhibit With Us
  • Board Room
  • Library
  • Contact Us